v3.25.4
Consolidated Statement of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities      
Net income (loss) $ 7,988,000,000 $ 9,245,000,000 $ 10,957,000,000
Adjustments to reconcile net income (loss) to net cash provided by operating activities      
Depreciation, depletion and amortization 11,500,000,000 9,599,000,000 8,270,000,000
Impairments 26,000,000 80,000,000 14,000,000
Dry hole costs and leasehold impairments 181,000,000 46,000,000 162,000,000
Accretion on discounted liabilities 378,000,000 325,000,000 283,000,000
Deferred taxes 549,000,000 367,000,000 1,145,000,000
Distributions more (less) than income from equity affiliates 200,000,000 564,000,000 964,000,000
(Gain) loss on dispositions (731,000,000) (51,000,000) (228,000,000)
Other (219,000,000) 130,000,000 (220,000,000)
Working capital adjustments      
Decrease (increase) in accounts and notes receivable 803,000,000 (262,000,000) 1,333,000,000
Decrease (increase) in inventories (116,000,000) (68,000,000) (103,000,000)
Decrease (increase) in prepaid expenses and other current assets (24,000,000) 79,000,000 337,000,000
Increase (decrease) in accounts payable (212,000,000) (543,000,000) (1,118,000,000)
Increase (decrease) in taxes and other accruals (527,000,000) 613,000,000 (1,831,000,000)
Net cash provided by operating activities 19,796,000,000 20,124,000,000 19,965,000,000
Cash flows from investing activities      
Capital expenditures and investments (12,553,000,000) (12,118,000,000) (11,248,000,000)
Working capital changes associated with investing activities 546,000,000 302,000,000 30,000,000
Acquisition of businesses, net of cash acquired 0 (24,000,000) (2,724,000,000)
Proceeds from asset dispositions 3,248,000,000 261,000,000 632,000,000
Net sales (purchases) of investments (55,000,000) 415,000,000 1,373,000,000
Other (22,000,000) 14,000,000 (63,000,000)
Net cash used in investing activities (8,836,000,000) (11,150,000,000) (12,000,000,000)
Cash flows from financing activities      
Issuance of debt 0 5,591,000,000 3,787,000,000
Repayment of debt (913,000,000) (4,981,000,000) (1,379,000,000)
Issuance of company common stock (100,000,000) (78,000,000) (52,000,000)
Repurchase of company common stock (5,018,000,000) (5,463,000,000) (5,400,000,000)
Dividends paid (3,995,000,000) (3,646,000,000) (5,583,000,000)
Other (76,000,000) (258,000,000) (34,000,000)
Net cash used in financing activities (10,102,000,000) (8,835,000,000) (8,661,000,000)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 153,000,000 (133,000,000) (99,000,000)
Net change in cash, cash equivalents and restricted cash 1,011,000,000 6,000,000 (795,000,000)
Cash, cash equivalents and restricted cash at beginning of period 5,905,000,000 5,899,000,000 6,694,000,000
Cash, cash equivalents and restricted cash at end of period $ 6,916,000,000 $ 5,905,000,000 $ 5,899,000,000